Top compounds associated with response to RASGRF2


Feature Type Standardized
Nominal ANOVA
mRNA THZ-2-49 GDSC1000 pan-cancer AAC -0.06 0.05
mRNA FK866 GDSC1000 pan-cancer AAC -0.06 0.05
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.058 0.05
mRNA shikonin GDSC1000 pan-cancer AAC -0.067 0.05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.06
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA Axitinib CTRPv2 pan-cancer AAC -0.064 0.06
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.065 0.06
mRNA KIN001-055 GDSC1000 pan-cancer AAC -0.065 0.06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.06
Download CSV